NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Long Term Provisions History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
---|---|---|---|---|---|
Long Term Provisions | ₹3.54 Cr | ₹3.00 Cr | ₹2.79 Cr | ₹2.61 Cr | ₹1.47 Cr |
What is the latest Long Term Provisions ratio of NATH BIOGENES (INDIA) ?
Year | Long Term Provisions |
---|---|
Mar2025 | ₹3.54 Cr |
Mar2024 | ₹3.00 Cr |
Mar2023 | ₹2.79 Cr |
Mar2022 | ₹2.61 Cr |
Mar2013 | ₹1.47 Cr |
How is Long Term Provisions of NATH BIOGENES (INDIA) Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2025 | ₹3.54 Cr | 18.10 | |
Mar2024 | ₹3.00 Cr | 7.64 | |
Mar2023 | ₹2.79 Cr | 6.74 | |
Mar2022 | ₹2.61 Cr | 77.74 | |
Mar2013 | ₹1.47 Cr | - |
Compare Long Term Provisions of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹330.8 Cr | 3.6% | -2.2% | -19.7% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹13,106.7 Cr | -4% | 3% | -25.9% | Stock Analytics | |
KAVERI SEED COMPANY | ₹5,866.6 Cr | -5.2% | -2% | 9.2% | Stock Analytics | |
VENKYS (INDIA) | ₹2,105.6 Cr | -1.2% | -0.6% | -31.9% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,362.5 Cr | -1.6% | -6.4% | -28.1% | Stock Analytics | |
INDO US BIOTECH | ₹280.7 Cr | -1.6% | -7.3% | -57.4% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | 3.6% |
-2.2% |
-19.7% |
SENSEX | -0.3% |
0.1% |
-1% |
You may also like the below Video Courses